ImmunityBio, Inc. IBRX Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by ImmunityBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about ImmunityBio, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ImmunityBio, Inc.'s common stock?
- ImmunityBio, Inc. (IBRX) reported common stock of 1.7B in Q1 2026.
- How has ImmunityBio, Inc.'s common stock changed year-over-year?
- ImmunityBio, Inc.'s common stock increased by 22.2% year-over-year, from 1.4B to 1.7B.
- What is the long-term trend for ImmunityBio, Inc.'s common stock?
- Over 5 years (2020 to 2025), ImmunityBio, Inc.'s common stock has grown at a 746.3% compound annual growth rate (CAGR), from 38K to 1.7B.
- What does common stock mean?
- The par value of the company's issued common shares.
- How do you interpret common stock?
- Changes typically reflect new share issuances or stock buybacks, impacting the company's capital base.
- How does common stock compare across companies?
- Standardized across all publicly traded companies, though par values are often nominal.